Human immunodeficiency virus type 1 KK26–27 matrix mutants display impaired infectivity, circularization and integration but not nuclear import  by Mannioui, Abdelkrim et al.
www.elsevier.com/locate/yviroVirology 339 (2Human immunodeficiency virus type 1 KK26–27 matrix mutants display
impaired infectivity, circularization and integration but not nuclear import
Abdelkrim Manniouia,b,c, Elisabeth Nelsona,b, Cecile Schiffera,b, Nathalie Felixa,b,
Erwann Le Rouzicd, Serge Benichoud, Jean Claude Gluckmana,b, Bruno Canquea,b,*
aUMR 7151 Centre National de la Recherche Scientifique-Universite´ Paris 7, 75010 Paris, France
bLaboratoire d’Immunologie Cellulaire et Immunopathologie de l’Ecole Pratique des Hautes Etudes, Institut Universitaire d’He´matologie,
Hoˆpital Saint-Louis, 75010 Paris, France
cLaboratoire de Biochimie and JFR 3012 Associe´e a` l’Agence Universitaire Francophone (AUPELF-UREF), Faculte´ des Sciences, Rabat, Morocco
dDe´partement des Maladies Infectieuses, Institut Cochin (INSERM U567, CNRS UMR8104), Universite´ Paris 5, Paris, France
Received 14 April 2005; returned to author for revision 11 May 2005; accepted 20 May 2005
Available online 16 June 2005Abstract
We analyzed the role of human immunodeficiency virus (HIV)-1 matrix protein (MA) during the virus replication afferent phase. Single-
round infection of H9 T lymphocytes showed that the combined mutation of MA Lys residues 26–27 in MA reported nuclear localization
signal (NLS)-1 [Haffar, O.K., Popov, S., Dubrovsky, L., Agostini, I., Tang, H., Pushkarsky, T., Nadler, S.G., Bukrinsky, M., 2000. Two
nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J. Mol. Biol. 299 (2),
359–368] impaired infectivity, abrogated 2-LTR-circle formation and significantly reduced integration. However, the mutation did not affect
viral DNA docking to chromatin in either interphasic or mitotic cells, indicating that MA N-terminal basic domain should not represent a
major determinant of HIV-1 nuclear import in T lymphocytes. These data point to a previously unreported role of MA in the late, post-
chromatin-binding, afferent phase of HIV-1 replication cycle.
D 2005 Elsevier Inc. All rights reserved.Keywords: HIV; Matrix protein; Nuclear import; Integration; HIV DNA circularizationIntroduction
Human immunodeficiency virus type 1 (HIV-1) has the
capacity to establish productive infection of non-dividing
cells such as resting T lymphocytes (TLs), macrophages or
dendritic cells (Canque et al., 1999; Mannioui et al., 2004). In
this case, most current evidence indicates that nuclear import0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.05.023
* Corresponding author. Laboratoire d’Immunologie Cellulaire et Immu
nopathologie de l’EPHE, CNRS UMR 7151, Institut Universitaire
d’He´matologie, Centre Hayem, Hoˆpital Saint Louis, 1 Avenue Claude
Vellefaux, 75475 Paris Cedex 10, France. Fax: +33 1 53 72 22 37.
E-mail addresses: karim.mannioui@chu-stlouis.fr (A. Mannioui)
elisabeth.nelson@chu-stlouis.fr (E. Nelson), cecile.schiffer@voila.fr
(C. Schiffer), bruno.canque@chu-stlouis.fr (B. Canque),
nathalie.felix@chu-stlouis.fr (N. Felix), lerouzic@cochin.inserm.fr
(E. Le Rouzic), benichou@cochin.inserm.fr (S. Benichou),
Jean-claude.gluckjman@chu-stlouis.fr (J.C. Gluckman).-
,of reverse transcription complexes (RTCs) is mediated via
interactions with shuttling transport receptors and nuclear
pore complex components, involving redundant viral nuclear
localization signals (NLS) displayed by viral proteins (Vpr,
integrase [IN], p17 matrix [MA]) or a DNA flap (central
polypurine tract) located at the viral DNA center (Sherman
and Greene, 2002).
Although it is admitted that Vpr and IN play important
roles at late post-reverse transcription stages of HIV-1
replication cycle, whether MA also contributes to nuclear
import and/or integration remains controversial. In this
respect, onemust keep inmind that, beside its pivotal function
in the assembly and budding of viral particles, MA also plays
an important role at early stages of the virus cycle,
conditioning its infectivity, uncoating and reverse transcrip-
tion (Bukrinskaya et al., 1998; Cannon et al., 1997; Casella et
al., 1997; Kiernan et al., 1998). Despite the presence of two005) 21 – 30
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(NLS-1) and 110 – 114 (NLS-2) (Bukrinsky et al.,
1993a,1993b; Haffar et al., 2000), MA displays only low to
marginal karyophily when tested in different nuclear import
and transfection assays (Depienne et al., 2000; Fouchier et al.,
1997). Although there is agreement that viruses mutated in
MANLS replicate poorly inmacrophages,whether this defect
primarily results from a block in RTC nuclear import remains
uncertain (Bukrinsky et al., 1993a,1993b; Haffar et al., 2000).
To date, most in vitro studies to detect virus nuclear import
are based on quantification of tandem 2-LTR circles formed
after ligation of the viral cDNA ends by the host cell non-
homologous DNA end-joining system (Li et al., 2001).
Although, 2-LTR circles are considered as relevant markers
of nuclear viral DNA (Bukrinsky et al., 1993a), they
represent only <5% of viral DNA (Brussel et al., 2003;
Butler et al., 2002; Pierson et al., 2002; Van Maele et al.,
2003) and whether they actually reflect ongoing virus nuclear
import remains questionable. For example, it has been
reported that mutations in the C- or N-terminus of Moloney
Murine Leukemia Virus (MLV) p12 Gag block viral DNA
integration and circularization without affecting the structure
or nuclear localization of RTCs (Yuan et al., 2002).
Here, we examined the role of MA N-terminal basic
domain spanning amino acids 26–32 in the afferent phase
of HIV-1 replication cycle in both dividing and non-
dividing TLs, with special emphasis on nuclear import
and integration.Results and discussion
Mitotic redistribution of HIV-1 MA, Vpr and IN proteins in
H9 TLs
We first investigated the sub-cellular distribution of viral
MA, Vpr and IN in either interphasic or metaphase-arrested
H9 TLs, which are CD3+CD4+TCRah+ clonal derivatives of
HUT78 cells (Popovic et al., 1984). Cells were transiently
transfected with the corresponding expression plasmids
(Depienne et al., 2000); 24 h later, they were arrested or
not in metaphase by Nocodazole and the sub-cellular
distribution of the proteins was examined 48 h post-trans-
fection. GFP-MA and Vpr-GFP were detected by direct
fluorescence and HA-IN by indirect immunofluorescence.
Nuclear pore complexes (NPCs) were also analyzed by
immunofluorescence, and cell DNA was visualized by 4V,6-
diamidino-2-phenylindole, dihydrochloride (DAPI) staining.
In line with a previous report (Vodicka et al., 1998), Vpr-
GFP predominantly localized at the nuclear envelope (NE)
of interphasic cells in close association with NPC proteins
(Fig. 1A). During mitosis, when NE breakdown provokes
the fragmentation of nuclear membranes and the disassem-
bly of NPCs, Vpr-GFP redistributed away from the nucleus
in vesicular structures dispersed throughout the cytoplasm.
Of note, that Vpr-GFP still co-localized with NPC proteinsin metaphasic cells suggests that the mitotic phosphorylation
of NPC proteins, which causes their redistribution into the
endoplasmic reticulum (Aitchison and Rout, 2002), does not
affect their interactions with Vpr.
Conversely to Vpr-GFP, non-myristiloyted GFP-MA
lacked detectable karyophily in interphasic cells, in which
it displayed a diffuse cytoplasmic localization (Fig. 1B).
During metaphase, GFP-MA remained excluded from the
nucleus, which demonstrates that it not only lacked
karyophily but also chromatin-binding capacity.
As expected (Cherepanov et al., 2000), HA-IN localized
in interphasic nuclei and remained tightly bound to mitotic
chromosomes after NE breakdown (Fig. 1C).
The MA KK27II mutation impairs HIV-1 replication in
H9 TLs
To investigate the contribution of MA N-terminal basic
domain to the virus cycle, a combined mutation of Lys to Ile
at residues 26–27 (KK27II) was introduced into either a
wild type (WT) or Vpr (KK27II Vpr) HIV-1NLHX genetic
background (Bukrinsky et al., 1993a,1993b). The effect of
the KK27II mutation on virus replication was then assessed
by exposing exponentially growing H9 TLs to graded
concentrations of WT or mutant viruses (0.4 to 50 ng p24
equivalent/3  106 cells). Virus spreading was followed by
sequential p24 dosage in culture supernatants over a 3-week
period (Figs. 2A–D). This showed that peak virus
production (925 to 1375 ng p24/104 cells) occurred on
days 9 to 12 post-infection (PI) in WT virus-infected cells,
whereas it was delayed in cultures infected with KK27II and
KK27II Vpr mutant viruses, p24 production reaching
lower maximum levels (30 to 500 ng p24/104 cells) only at,
or beyond day 15 PI. The data shown in Fig. 2 indicate that
the MA mutations impair virus replication in H9 TLs
(Bukrinsky et al., 1993a,1993b; Freed et al., 1995; Kiernan
et al., 1998) and confirm that MA and Vpr synergize to
promote HIV-1 replication (Vodicka et al., 1998).
Impact of the MA KK27II mutation on the afferent phase of
HIV-1 replication cycle
Single-cycle infections were performed next in order to
determine the stage at which the mutations affected virus
replication. H9 TLs were synchronized in G1 by double-
thymidin block before 2-h exposure to WT or mutant viruses
(1 Ag p24 equivalent/3  106 cells), and cells were then kept
arrested in G1b for 24 h with 5 Ag/ml Aphidicolin
(Mannioui et al., 2004). The efficiency of cell cycle arrest
was controlled by flow cytometry after labeling with a green
nucleic acid stain immediately after the second thymidin
block and 24 h later (Fig. 3A). Virus-exposed cells were
maintained in the presence of HIV-1 protease inhibitor
Saquinavir\ to prevent further re-infection. Real-time PCR
analysis to detect viral DNA formed after the second
template switch (referred to as total viral DNA thereafter)
Fig. 1. Sub-cellular localization of Vpr, MA and IN proteins in interphasic and mitotic H9 TLs. Exponentially growing H9 cells were transiently transfected with
(A) Vpr-GFP, (B) GFP-MAor (C) HA-IN; 24 h after transfection cells were arrested or not inmetaphase byNocodazole, and they were examined by confocal laser
microscopy 24 h later. HA-IN and NPCs were detected with rat anti-HA and Mab414 antibodies, respectively. Data are from one of two experiments.
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Fig. 2. Impact of the MAKK27II mutation on HIV-1 replication in H9 TLs. Exponentially growing H9 cells were exposed to graded concentrations of HIV-1NLHX
or KK27II Vpr+/ mutant viruses. Virus spreading in cells exposed to (A) 50, (B) 20, (C) 10 or (D) 0.4 ng p24 equivalent of each virus was followed by
sequential p24 dosage in culture supernatants. Data are from one of two experiments.
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prevent contamination by the plasmids used to prepare virus
stocks, virus-exposed cells were systematically treated with
DNAse, EGTA and MgCl2 for the last 2 h of infection. This
procedure removes 95% of contaminant plasmids in virus
supernatants as assessed by PCR to detect the plasmids’
ampicillin-resistance gene (data not shown) (Koh et al.,
2000; Mannioui et al., 2004).
At 24 h PI, total viral DNA copy numbers averaged
15,887 T 5114 per 104 WT virus-infected cells relative to
5218 T 1025 and 997 T 253 (mean T SEM, n = 4) for the
KK27II and KK27II Vpr mutants, which corresponded to
3- and 16-fold lower levels, respectively (Fig. 3B). At that
time, 7- and 41-fold lower copy numbers of integrated viral
DNA was also noted in KK27II mutant virus-infected cells
(Fig. 3C). To specifically assess late stages of the afferentvirus replication cycle, integrated viral DNA levels detected
by Alu-LTR PCR were normalized relative to 103 copies
total viral DNA (referred to as normalized integrated viral
DNA thereafter). Proviral DNA copy numbers were then
79 T 44 and 53 T 31 in KK27II and KK27IIVpr mutant
virus-infected cells, respectively, relative to 272 T 65
(mean T SEM, n = 4) in WT virus-infected cells (Fig.
3D). To confirm these findings, normalized integrated viral
DNA levels were sequentially determined over 48 h.
Because a significant fraction of H9 TLs underwent
apoptosis after 36-h Aphidicolin treatment (data not shown),
infections were performed with exponentially growing cells.
Alu-LTR PCR analysis at 48 h PI confirmed that KK27II
mutant virus-infected cells harbored 2- to 3-fold lower
integrated viral DNA levels than cells exposed to WT virus
(Fig. 4A). The possibility that the mutation delayed viral
Fig. 3. Impact of the MAKK27II mutation on the afferent phase of HIV-1 replication cycle. (A) Experimental design: synchronized H9 cells were exposed to
HIV-1NLHX or KK27II Vpr
+/ mutants (1 Ag p24 equivalent/3  106 cells) for the last 2 h of a double-thymidin block; cells were kept arrested in G1b by
Aphidicolin and analyzed for DNA content at the indicated time points. Real-time PCR analysis was performed 24 h PI. (B) Total viral DNA copy numbers (R-
gag PCR): data normalized relative to 104 cells are shown as means T SEM (n = 4). (C, D) Integrated viral DNA copy numbers (Alu-LTR nested PCR)
normalized relative (C) to 104 cells or (D) to 103 copies total viral DNA (means T SEM copy numbers; n = 4).
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levels did not change between 24 and 48 h PI. These data
confirm that the KK27II mutation hampers a post-reverse
transcription stage of HIV-1 replication cycle.
Because limited amounts of total viral DNAwere detected
24 h PI in KK27II Vpr+/ mutant virus-infected cells, we
next more thoroughly examined the impact of this mutation
on virus infectivity. G1-arrested H9 TLs were thus exposed
as above to graded amounts of WTor mutant viruses (0.04 to
1 Ag p24 equivalent/3  106 cells), and they were analyzed
by R-U5 PCR to detect minus strand strong stop DNA 4 h PI,
when most viral DNA molecules are assumed to carry only
one LTR. Three- to 7-fold lower viral DNA levels were then
noted in cells infected with mutant viruses, indicating that
the KK27II mutation actually impairs virus infectivity (Fig.
4B). Since viral RTCs are a substrate for proteosomal
degradation (Butler et al., 2002), we ruled out the possibility
that mutant viruses might be less stable than WT HIV-1NLHX
by showing that total viral DNA levels remained stable
between 8 and 24 h PI in mutant as well as in WT virus-
infected cells (data not shown). Of note, that overall similar
viral DNA levels were detected by R-U5 and R-gag PCRs
during this period indicates that the KK27II MA mutation
does not exert any significant effect on virus reverse
transcription (data not shown).
Finally, the finding that, upon exposure to <1 Ag p24
equivalent of the mutant viruses, integrated viral DNA levels
were below the Alu-LTR PCR detection threshold (20 copies
proviral DNA/104 cells) confirmed that the mutation affectslate stages of the afferent phase of HIV-1 replication cycle
(Fig. 4C).
Altogether, these data indicate that the reduced capacity
of KK27II mutant viruses to spread among TLs results from
the combination of an early entry or post-entry infectivity
defect and an ensuing post-reverse transcription block.
The defective integration of MA KK27II mutants is
independent of cell division
We have shown previously that NE fragmentation during
mitosis actually promotes HIV-1 RTC docking to chromatin,
thereby accounting for the increased permissiveness of
dividing TLs to the virus (Mannioui et al., 2004). Hence, if
mutants were deficient as regards nuclear import, one would
expect that NE disassembly alleviated the integration defect.
To address this point, we examined the impact of cell
division on the nuclear import and integration of MAKK27II
mutants. G1-synchronized H9 TLs were exposed to WT or
mutant viruses, before being either kept arrested in G1b by
Aphidicolin or released to synchronously progress through
mitosis, which occurs 8 to 10 h later (Mannioui et al., 2004).
Alu-LTR PCR analysis, 24 h PI, showed 3-fold greater
levels of integrated provirus in cells that went through
mitosis, with overall similar differences being noted
between the WT and mutant viruses (Fig. 5). These results
indicate that the reduced capacity of mutant viruses to
complete the afferent phase of infection does not depend on
NE disassembly.
Fig. 4. Impact of the MAKK27II mutation on virus infectivity and integration. (A) Exponentially growing H9 cells were exposed to HIV-1NLHX or KK27II
Vpr+/ mutants (1 Ag p24 equivalent/3  106 cells); Alu-LTR nested PCR analysis was performed at 24 and 48 h PI. (B, C) Synchronized H9 cells exposed
to graded concentrations of WT or mutant viruses (0.04 to 1 Ag p24 equivalent/3  106 cells) were kept arrested in G1b by Aphidicolin; (B) R-U5 or (C)
Alu-LTR PCR analysis was performed 4 or 24 h PI; data are normalized relative to (B) 104 cells or (C) 103 copies total viral DNA. Data are from one of
two experiments.
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Wenext focused on the post-reverse transcription stages of
the virus replication cycle, arguing that the mutation could
interfere with viral nuclear import, RTC docking to chroma-
tin, as well as with viral DNA integration. To more
specifically assess nuclear import, G1-arrested cells that
had been exposed as before to WT or mutant viruses were
submitted to 2-LTR-circle PCR analysis 24 h PI. At that time,
only WT virus-infected cells harbored detectable amounts of
tandem 2-LTR circles, which represented from 0.2 to 1% of
total viral DNA (1 to 10 copies/104 cells). Of note, the 2-LTR
PCR assay used here is based on the detection of 2-LTR
junctions by fluorescent hybridization probes, which ensures
an absolute specificity, and it can detect as few as 1 copy
tandem 2-LTR circles/104 cells (see Materials and methods).In as much as the mutation also impairs virus
infectivity, the lack of detectable 2-LTR circles in mutant
virus-infected cells might be related either to limited viral
DNA amounts or to defective nuclear import or circular-
ization. To discriminate between these possibilities, we
used non-integrative IND64A derivatives of the WT and
mutant viruses. These viruses, which are profoundly
defective for integration, display approximately 10-fold
greater 2-LTR circle forming capacity than the WT virus
(Figs. 6A–C). G1-synchronized H9 TLs were thus
exposed, as before, to IND64A derivatives of WT or
KK27II Vpr+/ viruses, and allowed or not to undergo
mitosis before PCR analysis 24 h later. This led to the
unexpected finding that the mutation totally abrogated 2-
LTR circle formation (Fig. 6D). Interestingly, virus with a
single stop mutation in Vpr coding sequence displayed a 2-
Fig. 5. Influence of cell division on the integration of KK27II mutant
viruses. G1-synchronized H9 cells exposed to the WT or mutant viruses
were either kept arrested in G1b by Aphidicolin (G1b) or released (REL)
from the thymidin block to synchronously progress through mitosis; real-
time Alu-LTR PCR analysis was performed 24 h PI; results are normalized
relative to 103 copies total viral DNA (means T SEM, n = 3).
Fig. 6. The MAKK27II mutation blocks 2-LTR circle formation. (A–C) Circula
synchronized H9 cells exposed to the WT or IND64A viruses were arrested in G1b
PCR analysis was performed 24 h PI; results are normalized relative to 104 cells; d
on the circularization of non-integrative IND64A mutants: H9 cells were exposed
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virus (data not shown), which stresses the specificity of the
effect of the MA KK27II mutation on viral DNA
circularization. Finally, that similar data were obtained in
dividing as well as in G1b-arrested TLs raised the
hypothesis that mutant viruses could be intrinsically
deficient for both viral DNA circularization and integra-
tion, rather than for nuclear import.
The MA KK27II mutation does not affect HIV-1 RTC
docking to chromatin
To directly examine this point, using a previously
described cell fractionation assay (Mannioui et al., 2004),
we examined the effect of the MA KK27II mutation on viral
DNA docking to mitotic as well as to interphasic chromatin.
H9 TLs that had been arrested in G1b or metaphase by
Aphidicolin or Nocodazole, respectively, were exposed to
non-integrative WT or MA KK27II mutants before being
subjected to sub-cellular fractionation to isolate post-nuclear
chromatin (Fig. 7A). Interphasic chromatin was obtained byrization of a non-integrative IND64A derivative of WT HIV-1NLHX: G1-
by Aphidicolin; (A) real-time LTR-gag, (B) Alu-LTR, and (C) 2-LTR circle
ata are from one of two experiments. (D) Impact of the MAKK27II mutation
to WT or mutant viruses and analyzed by real-time PCR as in Fig. 5.
Fig. 7. The MAKK27II mutation does not affect virus docking to chromatin. (A) Experimental design: G1b- and metaphase-arrested H9 cells were exposed to
non-integrative derivatives of the WT or mutant viruses, and further cultured for 24 h under the same conditions, i.e., with Aphidicolin or Nocodazole. (B)
Western blot analysis of purified chromatin (chr) and cytoplasmic (cyt) cell fractions. (C, D) Determination of chromatin-bound viral DNA: chromatin isolated
from (C) G1b- or (D) metaphase-arrested cells was analyzed by R-gag PCR. Data are normalized relative to total viral DNA quantified in the cells prior to
lysis. Data are from one of two experiments.
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while metaphase-arrested cells were submitted to hypotonic
lysis before mitotic chromosome purification by centrifu-
gation over a sucrose cushion. The purity of the chromatin
preparations was controlled by real-time PCR for mitochon-
drial cytochrome b (data not shown) and by Western
blotting for detecting the presence of nuclear histone H1
and the lack of cytosolic lactate-dehydrogenase (LDH) (Fig.
7B). Chromatin-associated viral DNA was then quantified
by R-gag PCR relative to viral DNA levels detected prior to
cell fractionation. Hence, we found that, although NE
disassembly increased chromatin-associated viral DNA
levels, which is in line with our previous data (Mannioui
et al., 2004), the MAKK27II mutation did not affect viral
DNA nuclear import or docking to either interphasic or
mitotic chromatin (Figs. 7C, D).Conclusions
Altogether, the results presented here do not provide
evidence that MA N-terminal basic domain represents akey regulator of HIV-1 nuclear import in TLs (Sherman
and Greene, 2002). Instead, they indicate that the MA
KK27II mutation not only impairs virus infectivity at, or
immediately after entry into its target cells, but also
significantly affects late post-chromatin binding events of
the virus replication cycle, pointing thus to a previously
undisclosed function of this protein in virus integration.
Hence, we propose that p17 MA plays an important role in
mediating interactions between chromatin-bound RTCs and
the molecular machinery involved in HIV-1 integration and
circularization.Materials and methods
Cell synchronization, viruses and infections
H9 cell cultures and synchronization by double-thymidin
block were performed as described (Mannioui et al., 2004).
Cell DNA content was controlled by flow cytometry
(FACScalibur, Becton-Dickinson, Mountain View, CA)
after labeling with the SYTOX cell-permeant nucleic acid
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ular Probes Inc, Eugene, Or). At the end of the second
block, cells were washed and released to synchronously
progress through the cell cycle. Alternatively, cells were
kept arrested in G1b by 5 Ag/ml Aphidicolin or they were
blocked at the metaphase/anaphase transition by 500 ng/ml
Nocodazole (both from Sigma-Aldrich, St. Quentin Fallav-
ier, France).
The pNLHX molecular clone and MAKK27IIVpr
+/
mutants were kindly provided by Dr M. Bukrinsky (The
Picower Institute for Medical Research, NY). A PCR-based
mutagenesis strategy (XL-Site-Directed Mutagenesis kit,
Stratagene) was used to introduce site-directed mutations in
the IN gene (IND64A) of clone pNL4-3. The mutated
fragment was then ligated with the appropriately digested
gel-purified pNLHX DNA backbone, and the region of the
resulting plasmid was sequenced. Viruses were produced by
transient transfection of 293T cells with 60 Ag of WT or
mutant pNLHX plasmids. Culture supernatants were har-
vested 48 and 72 h later, centrifuged and normalized based
on p24 content (Coulter HIV-1 p24 Antigen Assay, Beck-
man Coulter, Villepinte, France).
For single-round infection, H9 cells were exposed in
spinoculation (1200 g, 25 -C) to WT or mutant viruses (1 Ag
p24 equivalent/3  106 cells) for the last 2 h of the double-
thymidin block. They were then washed, cultured for
another 24 h with Saquinavir (1 Ag/ml; Roche Pharmaceut-
icals, Hertfordshire, UK), and treated with DNAse (20 U/
ml), 2 mM EGTA and 10 mM MgCl2 to remove
contaminant plasmids.
R-U5 (strong stop viral DNA), R-gag (total viral DNA),
2-LTR circle and Alu-LTR (integrated viral DNA) PCRs
have been described elsewhere (Mannioui et al., 2004). R-
U5 sense primer 5V-CTA ACTAGGGAACCCACG (M667,
nt 498–516), R-U5 antisense primer 5V-CTGCTAGA-
GATTTTCCA CAC (AA55, nt 616–635); R-gag sense
primer M667, R-gag antisense primer 5V-TCCTGCG-
TCGAG AGATCTC (M661B, nt 678–696). R-U5 and R-
gag PCR products were detected with SyberGreen dye
(Roche), while plasmid pNL4-3 was used to generate
standard curves (range: 0.6  102 to 6  107 copies).
Two-LTR circles were amplified with M677 sense primer
5V-GGAACCCACTGCTTAAGCC (nt 506–524) and 2-
LTRB antisense primers (2-LTRB: 5V-TGTGTAGTTCTGC-
CAATCAGG, nt 75–95), with subsequent detection of the
corresponding amplicons by hybridization probes 2-LTRFL
(5V-CCCGTCTGTTGTGTGACTCTGGTAACTAG, nt
563–591) and 2-LTRLC (5V-GATCCCTCAG ACCCTTTT-
AGTCAGTGTG, nt 593–620). Standard curves generated
by serial dilutions of the 2-LTRA plasmid into genomic cell
DNA (0.2 to 2  105 copies/104 cells) showed that
sensitivity of this assay was 1 copy/104 cells.
Integrated viral DNA was quantified by Alu-LTR nested
PCR, essentially as described (Mannioui et al., 2004);
detection of the corresponding amplicons was achieved with
hybridization probes LTR-FL (5V-CACAACAGACGGG-CACACACTACTTGA, nt 549–575) and LTR-LC (5V-
CACTCAAGG CAAGCTTTATTGAGGC, nt 522–546).
Standard curves for integrated viral DNA were generated
using HeLa cells infected with a Denv HIV-1 R7 Neo virus
and selected by culture with G418. Integrated viral DNA
amounts were normalized relative to total viral DNA copy
numbers.
Results were normalized relative to h-globin copy
numbers assessed with primer sense PCO4 (5V-CAACTT-
CATCCACGTTCACC) and antisense GH2O (5V-GAA-
GAGCCAAGGACAGGTAC). Standard curves were
generated using the Control DNA kit (Roche Diagnostics).
Quantification was achieved using the second-derivative
maximum methods provided by the LightCycler software
v.3.5.3 (Roche Diagnostics).
Transient transfections
Exponentially growing H9 cells were transiently trans-
fected with GFP-MA and Vpr-GFP eukaryote expression
vectors (Depienne et al., 2000) using the DEMRIE-C
reagent (Gibco BRL). Metaphase arrest was achieved by
adding Nocodazole to culture medium 24 h after trans-
fection, and mitotic cells were examined 24 h later. MA and
Vpr distribution was examined by direct fluorescence. HA-
IN was detected with the 12CA5 anti-HA rat monoclonal
antibody (Roche Diagnostics). NPCs were labeled with the
Mab414 antibody (Abcam Limited). Primary antibodies
were revealed by Alexa fluor 594-conjugated goat anti-
mouse IgG (Molecular Probes). Chromatin was stained with
DAPI.
Chromatin isolation
Sub-cellular fractionation was performed at the indicated
time points, as described (Mannioui et al., 2004). Inter-
phasic cells were lysed in buffer A (20 mM HEPES, pH 7.4,
150 mM KCl, 5 mM MgCl2, 1 mM EGTA) supplemented
with 0.025% digitonin (Sigma-Aldrich), and centrifuged to
isolate intact nuclei (1000  g, 10 min, 4 -C). The NE was
solubilized in buffer A supplemented with 1% deoxycho-
late, before chromatin was sedimented (16,000  g, 30 min,
4 -C). Metaphase-arrested cells were lysed in hypotonic
buffer B (20 mM HEPES, pH 8.5, 5 mM MgCl2, 10 mM
EDTA, 1 mM DTT) supplemented with 20 Ag/ml cytocha-
lasin B (Alexis Biochemicals) before mitotic chromosomes
were pelleted (10,000  g, 10 min, 4 -C), resuspended in
buffer C (10 mM HEPES, pH 7.5, 2 mM MgCl2, 25 mM
KCl, 1 mM DTT, 250 mM sucrose) supplemented with 1%
deoxycholate, and purified by sedimentation through 1-M
sucrose (1000  g, 20 min).
The purity of chromatin preparations was controlled by
Western blotting. Cells extracts were resolved by SDS-
PAGE and transferred onto a polyvinylidene difluoride
membrane (Immobilin-P, Millipore), before incubation with
sheep anti-LDH polyclonal antibodies (Cortex Biochem) or
A. Mannioui et al. / Virology 339 (2005) 21–3030a mouse anti-histone H1 monoclonal antibody (Santa Cruz
Biotechnology); labeling was detected by a peroxidase-
conjugated secondary monoclonal antibody.Acknowledgments
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